The global pelvic floor diagnostics market is expected to reach a value of 2,056.74 million USD in 2023, with significant growth expected over the next decade. By 2033, the market is expected to reach 3,753.39 million USDwhich corresponds to a compound annual growth rate (CAGR) of 6.2%.

The report highlights a significant increase in demand for advanced diagnostic technologies, particularly uroflowmetry devices and anal manometry systems. These segments are forecast to register a robust CAGR of 8.2% throughout the assessment period, underscoring their increasing importance in the diagnosis and treatment of pelvic floor disorders.

This growth is due to the increasing prevalence of pelvic floor disorders and the increasing importance of precise, non-invasive diagnostic solutions. The advancement of diagnostic technologies and an increased focus on patient-centered care are driving market expansion and innovation.

Improvements in reimbursement structures have motivated manufacturers to invest in the field of pelvic floor diagnostics, thus creating a favorable environment for sustainable growth until 2033.

Rising health care spending as well as increasing government support through grants and faster approvals have led to the establishment of pelvic floor diagnostic laboratories and a larger number of specialists.

The increasing number of private and government funding for pelvic floor diagnostics has increased the focus on innovative research solutions for the development of advanced testing systems.

Healthcare standards with advanced diagnostics have gained ground over the past two decades with rising incomes and increased investment in research. The pelvic floor diagnostics market has seen a significant shift in the adoption of molecular diagnostic devices.

Key findings from the market study on pelvic floor diagnostics

• Ultrasound systems are expected to account for 37.1% of revenue in 2021, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period.
• Due to their higher purchasing power, hospitals will increase revenue and account for over 60% of the value share by 2031.
• Mexico is expected to experience an average annual growth rate of 6.1% through 2031, supported by growing access to world-class medical facilities.
• K. and France are leading markets in Europe, accounting for over 20% and over 18% of the European market respectively in 2021.
• The United States is the largest and fastest growing market in North America, with a compound annual growth rate (CAGR) of 5.7% during the forecast period.

“The growing geriatric population worldwide is prone to pelvic floor disorders. Advances in diagnostics, including imaging and ultrasound systems, coupled with investments in research and academic institutions will therefore fuel the growth of the pelvic floor diagnostics market in the coming decade.”, says an analyst from Future Market Insights.

Investments in technology development offer growth opportunities

The pelvic floor diagnostics market has become a lucrative research area for pelvic dysfunction. The development of imaging technology is gaining importance with the increasing demand for high-resolution images.

The demand is fueled by the increasing awareness among the growing population about the available diagnostic options. Ultrasound systems provide reliable high-resolution images. The evolution of the processes for detecting, diagnosing and treating related diseases is expected to lead to a surge in demand in the pelvic floor diagnostics market.

Who wins?

The key players in the pelvic floor diagnostics market are focused on exploiting the market potential through strategic mergers and acquisitions. This is driven by the efficiency of innovative and specialized product portfolios. The market is also expected to grow due to increasing research and development activities for the diagnosis of pelvic floor disorders.

Some of the leading players in the pelvic floor diagnostics market include Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology sro, EndoMed Systems, Richard Wolf, Schölly Fiberoptic, Zhuhai Seesheen Medical Technology, KARL STORZ, Cadwell, The Prometheus Group, Neurosoft and Noraxon USA.

Click here to view an old full report analysis.

Segments:

By product:

• Urodynamic systems
• Uroflowmetry devices
• Anal manometry systems
• Cystoscopes
• Ultrasound systems
  • On cart/trolley basis
  • Portable Bladder Ultrasound Systems
• EMG

By end user:

• Hospitals
• Diagnostic imaging centers
• Special clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award recipient and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that are driving demand in the market. FMI is the world’s leading provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a huge team of over 400 analysts worldwide, FMI offers global, regional and local expertise on various domains and industry trends in more than 110 countries.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For sales inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Þjórsárdalur| Blog | YouTube